| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.25T | 12.43T | 10.89T | 8.43T | 5.25T | 5.33T |
| Gross Profit | 7.06T | 7.03T | 5.38T | 5.38T | 4.37T | 4.04T |
| EBITDA | 2.58T | 2.97T | 2.41T | 1.90T | 1.85T | 1.40T |
| Net Income | 1.90T | 1.86T | 1.49T | 1.12T | 1.13T | 777.02B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 94.09T | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Total Debt | 77.54T | 67.30T | 61.23T | 62.41T | 46.73T | 43.07T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 20.88T | 20.52T | 19.59T | 17.23T | 17.02T | 16.80T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -450.29B | -10.31T | 13.03T | 9.46T | 34.51T |
| Operating Cash Flow | 0.00 | 6.42B | -9.84T | 13.43T | 9.84T | 34.90T |
| Investing Cash Flow | 0.00 | -186.95B | 3.99T | -10.68T | -2.20T | -10.14T |
| Financing Cash Flow | 0.00 | -861.12B | 8.31B | -977.14B | -1.08T | -436.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥21.15T | 10.49 | 9.58% | 2.73% | 0.27% | 11.86% | |
72 Outperform | ¥2.09T | 5.92 | 20.02% | 2.63% | 31.37% | 148.24% | |
71 Outperform | ¥16.35T | 10.71 | 9.14% | 2.38% | -9.15% | 19.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥31.29T | 13.60 | 9.01% | 2.94% | -2.14% | 1.56% | |
63 Neutral | ¥9.50T | 14.35 | 5.28% | 2.73% | 13.95% | 21.73% | |
59 Neutral | ¥3.51T | 11.81 | 10.23% | 3.93% | 0.46% | 6.87% |